Intensive care research at Subiaco
The St John of God Subiaco Hospital ICU is one of the busiest private ICUs in Australia. St John of God Hospital Subiaco admitted 1,586 adult patients to the Intensive Care Unit 2018/2019.
Our clinical research has the potential for broad benefits, while at the same time focuses on issues of particular importance to patients treated at our hospital.
The Intensive Care Research Group is also involved in REMAP-CAP, led by Prof Steve Webb as the Principal Investigator. This is an international adaptive randomised controlled trial (RCT) of treatments for community-acquired pneumonia that also includes patients with COVID-19.
• A/Professor Kwok Ho
• Dr Ed Litton: Research Fellow and Consultant Intensivist
• Dr David Morgan: Head of Department ICU and Consultant Intensivist
• Professor Steve Webb: Director of Clinical Trials St John of God Subiaco Hospital and Consultant Intensivist
Litton, E., Latham, P., et al. (2019). Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and metaanalysis. Intensive Care Medicine, 45 (9), 1190–1199.
Litton, E., Anstey, M., Broadhurst, D., Chapman, A. R., Currie, A., Ferrier, J., et al. (2020). Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT). BMJ open, 10 (6), e035930. doi. org/10.1136/bmjopen-2019-035930
Morgan, D., Platell, C., & Ho, K. M. (2020) The incidence and determinants of bariatric reoperations: a population-based cohort study. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery, 16 (5), 663–669. doi.org/10.1016/j.soard.2020.01.015
You may be interested in